Special Issue "Novel Therapeutic Targets in Cancer"
Deadline for manuscript submissions: 31 December 2021.
I would like to inform you that the Pharmaceuticals Special Issue “Novel Therapeutic Targets in Cancer” is now accepting manuscripts for publication. In recent years, significant advances have been made in the management of cancer with the introduction of targeted therapies and immunotherapy. However, there continues to be an unmet clinical need for those patients who progress while on novel therapies. Thus, the identification of new mechanisms involved in tumor progression is critical to improve survival in this population. The scope of this Special Issue is to publish translational articles with the potential to provide a rationale for new strategies in cancer treatment. Appropriate subjects include novel molecular targets, intrinsic pathways involved in tumor immune escape mechanisms, drug development, physiological and pharmacological bases of drug action, and metabolism. Contributions to this issue include submission of original articles, review, short communications, and editorials.
Dr. Carlo Marchetti
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- therapy resistance
- small molecule
- drug delivery
- metastasis and mitochondria
- Malignant Glioma: Novel Therapeutic Strategies in Pharmaceuticals (6 articles)
- Cancer Translational Biomarkers and Targeted Therapies in Pharmaceuticals (10 articles)
- Clinical Development of Cancer Treatment in Pharmaceuticals (2 articles)
- Anticancer Drugs in Pharmaceuticals (10 articles)
- Treatment Options and Therapeutics for Non-small Cell Lung Cancer in Pharmaceuticals (9 articles)
- Supportive and Palliative Cancer Treatment in Pharmaceuticals (3 articles)
- New Therapies for Hepatocellular Carcinoma in Pharmaceuticals (6 articles)